Literature DB >> 17332676

Adipose tissue, inflammation and endothelial dysfunction.

Jerzy Chudek1, Andrzej Wiecek.   

Abstract

During the last decade, white adipose tissue was recognized to be an active endocrine organ and a source of many proinflammatory cytokines, chemokines, growth factors and complement proteins. Many of these adipokines seem to play an important role in the pathogenesis of obesity-related diseases including accelerated atherosclerosis, arterial hypertension and some glomerulopathies. As endothelial dysfunction is one of the early stages of atherosclerosis, it is reasonable to consider that substances secreted by adipose tissue may influence directly or indirectly (for instance by induction of microinflammation) the function of endothelial cells. The aim of this review is to summarize the evidences and hypotheses concerning the role of adipokines in the pathogenesis of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17332676

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  23 in total

1.  Adipose tissue as regulator of vascular tone.

Authors:  Charlotte Boydens; Nele Maenhaut; Bart Pauwels; Kelly Decaluwé; Johan Van de Voorde
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

2.  Cardiovascular Consequences of Obesity and Targets for Treatment.

Authors:  Bettina Mittendorfer; Linda R Peterson
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 3.  Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue.

Authors:  Joseph M Rutkowski; Kathryn E Davis; Philipp E Scherer
Journal:  FEBS J       Date:  2009-09-15       Impact factor: 5.542

4.  Adiponectin, resistin and leptin in paediatric chronic renal failure: correlation with auxological and endocrine profiles.

Authors:  Maria Cristina Maggio; Daniela Montaperto; Silvio Maringhini; Ciro Corrado; Eleonora Gucciardino; Giovanni Corsello
Journal:  J Nephrol       Date:  2014-01-22       Impact factor: 3.902

5.  Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition.

Authors:  Jacky T C Liu; Erfei Song; Aimin Xu; Thorsten Berger; Tak W Mak; Hung-Fat Tse; Ivy K M Law; Bosheng Huang; Yan Liang; Paul M Vanhoutte; Yu Wang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  Cerebral hemodynamics in obesity: relationship with sex, age, and adipokines in a cohort-based study.

Authors:  Oscar Ayo-Martin; Jorge García-García; Francisco Hernández-Fernández; Mercedes Gómez-Hontanilla; Isabel Gómez-Fernández; Carolina Andrés-Fernández; Cristina Lamas; José Joaquín Alfaro-Martínez; Francisco Botella; Tomás Segura
Journal:  Geroscience       Date:  2021-01-15       Impact factor: 7.713

7.  Adipokines and their Relation to Endothelial Dysfunction in Patients with Chronic Kidney Disease.

Authors:  Madhusudan Ambarkar; Srinivasarao V L N Pemmaraju; Sivakrishna Gouroju; Suchitra M Manohar; Aparna R Bitla; Naresh Yajamanam; Sivakumar Vishnubhotla
Journal:  J Clin Diagn Res       Date:  2016-01-01

8.  Forearm blood flow response to acute exercise in obese and non-obese males.

Authors:  R Lee Franco; B A Fallow; C J Huang; E O Acevedo; J A Arrowood; R K Evans
Journal:  Eur J Appl Physiol       Date:  2013-04-05       Impact factor: 3.078

9.  Maternal diagnosis of obesity and risk of cerebral palsy in the child.

Authors:  Mary D Crisham Janik; Thomas B Newman; Yvonne W Cheng; Guibo Xing; William M Gilbert; Yvonne W Wu
Journal:  J Pediatr       Date:  2013-08-06       Impact factor: 4.406

Review 10.  Is adiposopathy (sick fat) an endocrine disease?

Authors:  H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard
Journal:  Int J Clin Pract       Date:  2008-08-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.